Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

More young people surviving cancer in England, despite significant economic divide

January 17, 2019 Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …
News
16792957331_d9572dbdf4_z

US regulator to recruit 50 new gene and cell therapy clinical reviewers

January 16, 2019 Research and Development FDA, cell therapy, gene therapy, regulation

FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …
News
merckincweb1

MSD’s Keytruda boosts overall survival by 31% in advanced oesophageal cancer

January 16, 2019 Research and Development Cancer, MSD, keytruda, oesophageal cancer, pharma

MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …
News

Breast cancer cells can be transformed into fat cells using combination therapy, study shows

January 16, 2019 Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours

An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …
News
novo_flag

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific

January 16, 2019 Manufacturing and Production, Medical Communications, Research and Development DKSH, Novo Nordisk, pharma

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …
News
5204602349_c87b204860_z

FDA halts allergy drug approval process due to government shutdown

January 15, 2019 Research and Development Aimmune, FDA, Trump, governmetn, shutdown

California-based pharma firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration …
News
douglas_watson

Former CEO of Novartis’ US operations joins board of cancer immunotherapy firm

January 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …
Appointment

Tumours with large number of mutations respond better to immunotherapies, study shows

January 15, 2019 Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour

Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …
News
shutterstock_212035546

Verona’s shares drop 34% on Phase 2 failure of nebulised ensifentrine in COPD

January 15, 2019 Manufacturing and Production, Research and Development Boehringer, COPD, Stiolto Respimat, pharma, trial failure, verona pharma

Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …
News
sean_bohen

AstraZeneca’s chief medical officer announces resignation amid wave of departures

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …
Appointment
nve00002_web

Living with Alström syndrome

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …
Feature
artificial-intelligence-2228610_640

Kyowa Hakko Kirin signs drug discovery deal with AI firm InveniAI

January 11, 2019 Medical Communications, Research and Development AI, InveniAI, Kyowa Hakko Kirin, artificial intelligence, drug discovery, pharma

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …
News
fmilogo

Foundation medicine name Roche SVP as new CEO

January 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the …
Appointment
sag_ebola

Scientists develop treatment for all strains of Ebola

January 10, 2019 Research and Development Ebola, primates, research UTMB, texas, zmapp

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026